Castle Biosciences CSTL 深 沪
等待开盘 07-02 09:30:00 美东时间
24.71
+0.860
+3.61%
华盛通- 最 高24.86
- 今 开23.92
- 成交量 31.83万股
- 最 低 23.86
- 昨 收 23.85
- 总市值 7.49亿
- 52周最高 44.28
- 市盈率 静 --
- 换手率 1.05%
- 52周最低 14.59
- 委 比 -90.99%
- 总股本 3033.00万
- 历史最高 107.69
- 量 比 0.64
- 振 幅 4.19%
- 历史最低 9.2601
- 每 手 1
- 风险率 7.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅135.66%！Ocular Therapeutix获Chardan Capital升目标价至23美元，维持"买入"评级
今日重点评级关注：Chardan Capital：维持Ocular Therapeutix"买入"评级，目标价从21美元升至23美元；Guggenheim：维持Amylyx Pharmaceuticals"买入"评级，目标价从30美元升至40美元
06-26 17:42
Castle Biosciences grants 204,925 inducement RSUs to 172 employees under 2022 plan
Castle Biosciences grants 204,925 inducement RSUs to 172 employees under 2022 plan Castle Biosciences granted RSUs to 172 newly hired employees covering 204,925 common shares under its 2022 Inducement Plan. The awards were granted on June 15, 2026. RSUs vest over four years, with 25% on the first an
06-19 19:00
SciBase, Castle Biosciences enroll first patient in DETECT-AD study testing EIS to predict atopic dermatitis flares
SciBase, Castle Biosciences enroll first patient in DETECT-AD study testing EIS to predict atopic dermatitis flares SciBase enrolled the first patient in DETECT-AD, a multicenter prospective study with Castle Biosciences in atopic dermatitis. Electrical Impedance Spectroscopy will be evaluated for i
06-10 14:46
Citrini看多美股医疗板块新行情，更新“卖铲人”篮子：AI利好叠加周期性改善，复苏信号更明确
曾凭借《2028年全球智能危机》这一“思想实验”报告迅速出圈的独立研究机构的Citrini Research近日对其医疗保健投资组合进行了更新，原因是该公司...
06-10 09:49
Citrini sees new upside in healthcare stocks, updates basket
Citrini Research has updated its healthcare basket as the firm grows increasingly bullish on a recovery in life sciences, bioprocessing, and healthcare infrastructure stocks driven by both cyclical im...
06-09 23:41
美股大行评级 | 潜在涨幅257.14%！瑞杰金融上调InflaRx目标价至9美元，评级升至"强烈买入"
今日重点评级关注：瑞杰金融：上调InflaRx评级至"强烈买入"，目标价从7美元升至9美元；巴克莱：维持Orchestra BioMed Hldgs"超配"评级，目标价从12美元升至13美元
05-14 14:32
BTIG Maintains Buy on Castle Biosciences, Lowers Price Target to $40
BTIG analyst Mark Massaro maintains Castle Biosciences (NASDAQ:CSTL) with a Buy and lowers the price target from $50 to $40.
05-13 17:48
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic May 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aecom, Humana and Mosaic on Wednesday. HIGHLIGHTS * Aecom ACM.N : RBC cuts target price to $111 from $142 * Humana HUM.N
05-13 15:31
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
美股大行评级 | 大摩上调Lumentum目标价从595美元升至710美元；康宁、道富银行、Ally Financial获多家机构上调目标价
今日重点评级关注：Canaccord Genuity：维持Vertical Aerospace"买入"评级，目标价从9.5美元升至10.5美元；Canaccord Genuity：维持AtaiBeckley Inc."买入"评级，目标价从14美元升至15美元
04-21 11:25
